Market Introduction
Artificial intelligence (AI) uses algorithms and software to perform specific tasks without human intervention and instructions. Artificial intelligence comprises the integration of several technologies, such as machine learning, natural language processing, reasoning, and perception. Artificial intelligence is used in healthcare to approximate human cognition and analyze complex medical and diagnostic imaging data. The artificial intelligence in the healthcare diagnosis market is driven by the ability of AI to improve patient outcomes, need to increase coordination between the healthcare workforce & patients.
Market Overview and Dynamics
The Asia Pacific artificial intelligence in healthcare diagnosis market is projected to expected to grow from US$ 729.99 million in 2019 to US$ 14,043.88 million by 2027. This represents a CAGR of 44.9% from 2020 to 2027. The growth of the Asia Pacific artificial intelligence in healthcare diagnosis market is attributed to Rising Adoption of Artificial Intelligence (AI) in disease identification and diagnosis, and Increasing investment in AI healthcare startups. However, the lack of skilled ai workforce and ambiguous regulatory guidelines for medical software limits the growth of market in this region. Countries in Asia Pacific are expecting to witness huge challenge due to growing COVID-19. Due to outbreak of disease, healthcare industries has been affected badly. Due to growing coronavirus cases, many business related activities such as product launches and product promotion conferences has been postponed, leading to restraining the growth of the market.
Key Market Segments
Based on Diagnostic Tool, the Asia Pacific artificial intelligence in healthcare diagnosis market is segmented into medical imaging tool, automated detection system, and others. In 2019, the medical imaging tool segment held a larger share of the market. Whereas, automated detection system segment is expected to grow at a faster rate during the forecast period.
Major Sources and Companies Listed
A few major primary and secondary sources referred to while preparing the Asia Pacific artificial intelligence in healthcare diagnosis market report are World Health Organization, Ministry of Health and Prevention, Medicines and Healthcare Products Regulatory Agency, and National Center for Biotechnology Information.
General Electric Company, Koninklijke Philips N.V., Aidoc, Arterys Inc., Icometrix, IDx Technologies Inc., MaxQ AI Ltd., Caption Health, Inc., Zebra Medical Vision, Inc., Siemens Healthcare Private Limited
Reasons to buy the report
ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE DIAGNOSIS MARKET SEGMENTATION
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 729.99 Million |
| Market Size by 2027 | US$ 14,043.88 Million |
| CAGR (2020 - 2027) | 44.9% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Diagnostic Tool
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Artificial Intelligence in Healthcare Diagnosis Market is valued at US$ 729.99 Million in 2019, it is projected to reach US$ 14,043.88 Million by 2027.
As per our report Asia Pacific Artificial Intelligence in Healthcare Diagnosis Market, the market size is valued at US$ 729.99 Million in 2019, projecting it to reach US$ 14,043.88 Million by 2027. This translates to a CAGR of approximately 44.9% during the forecast period.
The Asia Pacific Artificial Intelligence in Healthcare Diagnosis Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Artificial Intelligence in Healthcare Diagnosis Market report:
The Asia Pacific Artificial Intelligence in Healthcare Diagnosis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Artificial Intelligence in Healthcare Diagnosis Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Artificial Intelligence in Healthcare Diagnosis Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)